The company in question is, Illumina Inc. (NASDAQ:ILMN) currently with a stock price of 169.48 (-0.04% today). The market cap for Illumina Inc. is 24947.46, and is in the sector Healthcare, and Biotechnology industry. The target price for Illumina Inc. is 154.88. Currently Illumina Inc. is trading with a P/E of 58.26, and a forward P/E of 41.49. Average volume for Illumina Inc. is 1193.37 and so far today it is 602000.
Performance in the last year for Illumina Inc. has been -13.40%. For EPS growth, Illumina Inc. has seen a growth of 30.50%, and is looking to grow in the next year to 15.72%. More long term stats show that EPS growth has been 28.90% over the last five years and could be 15.97% for the next five years. Illumina Inc. has seen sales growth quarter over quarter at 11.30%, with EPS growth quarter over quarter at 18.60%. The 20-day simple moving average is 10.27%, with the 200-day simple moving average coming to 7.45%.
Since the IPO date for Illumina Inc. on the 7/28/2000, Illumina Inc. has seen performance year to date to be -11.71%. With Illumina Inc. trading at 169.48, the dividend yield is *TBA, and the EPS is 2.91.
So could Illumina Inc., be undervalued? Well as said before P/E is 58.26. The PEG is 3.65, P/S is 10.78 and the P/B is at 12.1. The P/cash is 17.5, with P/free cash flow at 50.72.
Illumina Inc. ability to deal with debt shows that the current ratio is 3.7, and the quick ratio is 3.1. This is with long term debt/equity at 0.5, and total debt/equity at 0.5.
In terms of margins, Illumina Inc. has a gross margin of 70.00%, an operating margin of 24.60% and a profit margin of 18.70%.Payout ratio for Illumina Inc. is 0.00%. Return on assets come to 11.40% with return on investment coming to 16.60%.
Insider ownership for Illumina Inc., is at 1.20% and institutional ownership comes to 97.70%. Outstanding shares are at 147.2. While shares float is 145.1. The float short is currently 4.45%, and short ratio is 5.41.